Monitoring Melanoma with Molemapping
Molemapping including Total Body Photography is the most efficient way to detect melanoma. Melanoma patients have a 12% chance of developing a new primary melanoma in the future. Patients who have already been diagnosed with melanoma need regular followup molemaps to help detect any future new melanoma primaries. Subsequent melanomas found through molemapping are usually thinner than the first melanoma with a better prognosis.
The best surveillance program for early melanoma detection is Molemapping with Total Body Photography. Molemapping will detect new moles and changing moles, both seen as indicators for melanoma. Most melanomas arise as a new mole and will change in size. The bodyshots will assist in determining which mole is new and digital comparison images with Molemax technology will detect changing moles. If molemapping is not available then a skincheck with Total Body photography is a good option.
When a patient is diagnosed with a melanoma there is a 12% chance that they will develop a second primary melanoma somewhere else on their skin not associated with the first melanoma. It is vital to have a comprehensive surveillance program for these melanoma patients to monitor for new primaries.
Dr Sally Shaw, skin cancer expert at Peninsula Skin Cancer Centre, says that the combination of Molemapping with Total Body photography is the gold standard for melanoma monitoring. “Patients diagnosed with melanoma are enrolled in our melanoma molemapping program to ensure we can detect any new melanomas at the earliest stage” said Dr Shaw.
“Our melanoma molemapping program combines Total Body Photography and Molemax Digital Imagery” said Dr Shaw. “The 23 body shots are high resolution photos taken of each area of the body, recording the existing moles on the patient’s skin, establishing a baseline for future reference. Then every mole is examined using hand held dermatoscopy, assessed for features seen in skin cancer and any mole that appears suspicious is imaged using Molemax technology. These images are highly magnified and are used to monitor for subtle changes within that mole over short term and long term monitoring.”
“When a new mole is detected on a patient over the age of 50 or an existing moles shows changes, then a biopsy is required to rule out melanoma and in most cases the subsequent melanoma was thinner than the first primary melanoma” she said. “Molemapping has ensured that 83% of the melanomas detected in our clinic are still insitu, it hasn’t penetrated through the epidermis and become invasive. Insitu melanomas have a survival rate of 96-10% over 5 years”.
More information on using Molemapping to monitor for melanoma can be found here.
( Press Release Image: http://photos.webwire.com/prmedia/50016/205514/205514-1.jpg )
- Contact Information
- Sue Dixon
- Marketing Officer
- Peninsula Skin Cancer Centre
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.